With the recent announcement of the USAID/Janssen Bdq Donation Program, there is now an opportunity for increased access to this new tool for the treatment of drug-resistant tuberculosis. This webinar will review the 5 conditions, specified by the WHO in their interim policy guidelines, with practical guidance for helping countries and programs introduce bedaquiline in an optimal way.

Thursday 19 March 2015, 10:00 AM - 11:00 AM
Time Zone: (GMT-05:00) Eastern Time (US and Canada) (Please note that Daylight Saving Time (+01:00 hr) is in effect during this time)